Masimo Corp
Medical Devices · Healthcare
Equibles does not estimate personal net worth.
Masimo Corp reported in an 8-K filed November 18, 2024 that Tao Levy was terminated as Executive Vice President, Business Development, effective November 13, 2024. The proxy statement of Masimo Corp reports total compensation of $1,831,393 for Tao Levy in fiscal 2021, including a base salary of $362,461. Disclosed compensation is on record for 4 fiscal years.
“On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation (the “Company”) terminated the employment of Tao Levy, the Company’s Executive Vice President, Business Development.”
Masimo Corp
Proxy statement
Start not stated–2024-11-13
Masimo Corp
Medical Devices · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Masimo Corp | Executive Vice President, Business Development | $362,461 | $1,831,393 |
| 2020 | Masimo Corp | Executive Vice President, Business Development | $344,826 | $1,805,014 |
| 2019 | Masimo Corp | Executive Vice President, Business Development | $334,782 | $1,772,207 |
| 2018 | Masimo Corp | Executive Vice President, Business Development | $324,917 | $2,557,310 |